Literature DB >> 313700

Antibody against hepatitis A in seven European countries. II. Statistical analysis of cross-sectional surveys.

D Schenzle, K Dietz, G G Frösner.   

Abstract

The age-specific prevalence of hepatitis A antibodies has been analyzed using a catalytic epidemic model for populations in seven European countries: West Germany, Norway, Greece, Switzerland, Holland, France and Sweden. The results indicate a significant decline in the force of infection in recent decades. However, there are substantial differences between the countries, especially between the Scandinavian countries and Greece. The incidence of hepatitis A in Norway and Sweden has declined since 1930, while a downward trend in incidence in Greece may have started only recently.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 313700     DOI: 10.1093/oxfordjournals.aje.a112790

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  17 in total

1.  Decrease in incidence of hepatitis A infections in Germany.

Authors:  G Frösner; H Willers; R Müller; D Schenzle; F Deinhardt; W Höpken
Journal:  Infection       Date:  1978       Impact factor: 3.553

2.  Prevalence of hepatitis A antibodies in French recruits in 1985.

Authors:  M Joussemet; B Rouvin; R Deloince; D Esnault; G Fabre
Journal:  Eur J Epidemiol       Date:  1987-03       Impact factor: 8.082

3.  Injury to cervical spine after a game of British bulldog.

Authors:  J D Spencer; I W Bintcliffe
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22

4.  Prevalence and incidence of hepatitis A among male homosexuals.

Authors:  R A Coutinho; P Albrecht-van Lent; N Lelie; N Nagelkerke; H Kuipers; T Rijsdijk
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-10

5.  Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998.

Authors:  W Thierfelder; W Hellenbrand; H Meisel; E Schreier; R Dortschy
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

6.  The three-year incidence of non-B viral hepatitis morbidity in a controlled trial of pre-exposure immune serum globulin prophylaxis.

Authors:  J D Kark; E Witztum; H Mazkin; E Nili; Y L Danon
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

7.  Longitudinal study of Toxoplasma seroprevalence in South Yorkshire.

Authors:  J Walker; D J Nokes; R Jennings
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

8.  Evolution of hepatitis A antibodies prevalence in young French military recruits.

Authors:  M Joussemet; P Bourin; O Lebot; G Fabre; R Deloince
Journal:  Eur J Epidemiol       Date:  1992-03       Impact factor: 8.082

9.  Trends in hepatitis A virus infection with reference to the process of urbanization in the greater Madrid area (Spain).

Authors:  C Amela; I Pachón; R Bueno; C de Miguel; F Martinez-Navarro
Journal:  Eur J Epidemiol       Date:  1995-10       Impact factor: 8.082

10.  Changing epidemiological characteristics of acute viral hepatitis in Greece.

Authors:  G Papaevangelou; A Roumeliotou-Karayannis; P Contoyannis
Journal:  Infection       Date:  1982-01       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.